This symposium will bring together chemists from industry, academia and start-up companies from around the world and is focused on the most recent advances in new synthetic methodologies, total synthesis, chemical biology, process and medicinal chemistry, and automation & AI approaches in synthesis and drug discovery.

The general concept of the meeting, with talks equally selected from industry and academia, will include

• an opening lecture
• 26 invited lectures
• 10 oral communications selected from submitted abstracts
• A large poster session and commercial exhibition.

The 2025 edition of EFMC-ASMC is chaired by:

• Dr Malin Lemurell (AstraZeneca, Sweden)
• Prof. Nuno Maulide (University of Vienna, Austria)

Confirmed Speakers

• Synthesis in a Boron World
  Prof. Varinder K. AGGARWAL
  UNIVERSITY OF BRISTOL, Bristol, United Kingdom
• Flow Automation for Drug Discovery Expanding the Limits of Accessible Chemical Space
  Dr. Jesus ALCAZAR
  JANSSEN RESEARCH & DEVELOPMENT, Toledo, Spain
• Title to be announced
  Dr. Luke ASHCRAFT
  CYTOKINETICS, San Francisco, United States
• Recent Developments in Carbon Isotope Labeling
  Dr. Davide AUDISIO
  CEA-SACLAY, Gif-sur-Yvette, France
• Cryo-EM Enables Structure-Based Drug Design for Membrane Protein Targets at Boehringer Ingelheim
  Dr. Rebecca EBENHOCH
  BOEHRINGER INGELHEIM, Biberach, Germany
• Therapeutic Opportunities within the Ubiquitin System
  Dr. Malte GERSCH
  TU DORTMUND, Dortmund, Germany
• Boronic Acids a Useful Construction Tool for Chemical Biology
  Dr. Pedro GOIS
  UNIVERSITY OF LISBON, Lisboa, Portugal
• Two Nobel-prized Chemistries Combined Towards New Topical Treatments for Non-Healing Wounds
  Prof. Paula GOMES
  UNIVERSITY OF PORTO, Porto, Portugal
• Design and Synthesis of the WRN Inhibitor HRO761
  Dr. Jürgen HINRICHS
  NOVARTIS, Basel, Switzerland
• Title to be announced
  Dr. Elisa LIARDO
  MONTE ROSA THERAPEUTICS, Basel, Switzerland
• The Synergy of Light, Organocatalysis, and Enzymes: New Radical Opportunities
  Prof. Paolo MELCHIORRE
  UNIVERSITY OF BOLOGNA, Bologna, Italy
• Title to be announced
  Dr. Anneli NORDQVIST
  ASTRAZENECA, BIOPHARMACEUTICALS R&D, Gothenburg, Sweden
• Fragment-Based Discovery of Allosteric Modulators of β-Glucocerebrosidase (GCase)
  Dr. Nick PALMER
  ASTEX PHARMACEUTICALS, Cambridge, United Kingdom
• Break-it-to-Make-it Strategies for Chemical Synthesis Inspired by Complex Natural Products
  Prof. Richmond SARPONG
  UNIVERSITY OF CALIFORNIA, Berkeley, United States
• Discovery and in vivo Efficacy of Novel Aminopeptidase Modulators
  Dr. Christopher TINWORTH
  GLAXOSMITHKLINE, Stevenage, United Kingdom
• Title to be announced
  Prof. Dirk TRAUNER
  UNIVERSITY OF PENNSYLVANIA, Philadelphia, PA, United States
• Peptide Catalysis – From Simple to Complex Environments
  Prof. Helma WENNEMERS
  ETH ZURICH, Zürich, Switzerland
• Title to be announced
  Prof. M. Christina WHITE
  UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN, Urbana, United States
• Future-proofing Synthesis at AstraZeneca: Sustainability, Green Chemistry and Project Delivery
  Dr. Gail WRIGLEY
  ASTRAZENECA, Cambridge, United Kingdom
• HTE OS: Attaching Wings to Chemistry
  Dr. Georg WUITSCHIK
  F. HOFFMANN-LA ROCHE, Basel, Switzerland
• Vera JOST
  F. HOFFMANN-LA ROCHE, Basel, Switzerland